首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1588502

疫苗市場規模、佔有率、成長分析、按技術、按類型、按適應症、按管理途徑、按最終用戶、按地區 - 行業預測，2024-2031 年

Vaccines Market Size, Share, Growth Analysis, By Technology, By Type, By Disease Indication, By Route of Administration, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月06日 | 出版商:

SkyQuest | 英文 212 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球疫苗市場規模將為720億美元，從2023年的746.6億美元成長到2031年的998.5億美元，在預測期間（2024-2031年）預計複合年成長率為3.70%。

由於慢性病的流行和人們對醫療保健的興趣日益濃厚，預計全球疫苗市場將顯著成長。隨著醫療技術的發展和創新疫苗研發投資的加大，市場參與者可能會遇到新的機會。在新的免疫計劃和疫苗宣導活動的支持下，預防性醫療保健趨勢預計將推動疫苗的使用。此外，疫苗接種活動和疫苗技術的進步可能會進一步增強市場參與企業未來幾年的成長前景。然而，有關疫苗的廣泛錯誤訊息、高昂的市場開拓成本和嚴格的監管要求等挑戰可能會阻礙市場的進步。總體而言，疫苗市場可能會因全球健康挑戰和意識的提高而擴大，但相關人員需要克服這些障礙才能利用新的商機。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

GSK Plc（UK）
Merck & Co., Inc.（US）
Pfizer Inc.（US）
Sanofi（France）
CSL（Australia）
Emergent（US）
Johnson & Johnson Services, Inc.（US）
AstraZeneca（UK-Sweden）
Serum Institute of India Pvt., Ltd.（India）
Bavarian Nordic（Denmark）
Mitsubishi Tanabe Pharma Corporation（Japan）
Daiichi Sankyo Company, Limited（Japan）
Panacea Biotec（India）
Biological E Limited（India）
Bharat Biotech（India）
Novavax（US）
Inovio Pharmaceuticals（US）
Sinovac（China）
Incepta Pharmaceuticals Ltd.（Bangladesh）
Valneva SE（France）
VBI Vaccine Inc.（US）
Bio Farma（Indonesia）
Microgen（Russia）
ZHI FEI Biological（China）
Indian Immunologicals Limited（India）

簡介目錄

Product Code: SQMIG35H2262

Global Vaccines Market size was valued at USD 72 billion in 2022 and is poised to grow from USD 74.66 billion in 2023 to USD 99.85 billion by 2031, growing at a CAGR of 3.70% during the forecast period (2024-2031).

The global vaccines market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and a heightened focus on healthcare. As medical technology evolves and investment in research and development of innovative vaccines intensifies, market players are likely to encounter new opportunities. The trend towards preventive healthcare is expected to foster greater vaccine adoption, supported by the introduction of new immunization programs and vaccine awareness initiatives. Furthermore, vaccination drives and advancements in vaccine technology will further enhance growth prospects for market participants over the forthcoming years. However, challenges such as widespread misinformation about vaccines, significant development costs, and strict regulatory requirements may hinder market progression. Overall, while the vaccines market is set to expand in response to global health challenges and growing awareness, stakeholders must navigate these obstacles to capitalize on the emerging opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaccines Market Segmental Analysis

Global Vaccines Market is segmented by Technology, Type, Disease Indication, Route of Administration, End User, and region. Based on Technology, the market is segmented into Conjugate Vaccines, Recombinant Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Viral Vector Vaccines, MRNA Vaccines, and Other Vaccines. Based on Type, the market is segmented into Multivalent Vaccines, and Monovalent Vaccines. Based on Disease Indication, the market is segmented into Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, and Other Disease Indications. Based on Route of Administration, the market is segmented into Oral Route (PO), Intranasal Route (NAS), Subcutaneous Route (Subcut), Intramuscular Route (IM). Based on End User, the market is segmented into Adult Vaccines, and Pediatric Vaccines. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Vaccines Market

The surge in the incidence of infectious and chronic diseases globally has significantly heightened awareness regarding the importance of preventive healthcare, acting as a key market driver for the global vaccines market. As populations become more cognizant of the benefits associated with vaccination, the demand for effective and reliable vaccine solutions is set to rise. Vaccines not only help in thwarting the spread of diseases but also play a crucial role in alleviating healthcare burdens before they escalate into major health crises. Consequently, this increasing awareness and proactive health management are expected to catalyze substantial growth in vaccine sales across diverse demographics.

Restraints in the Global Vaccines Market

The Global Vaccines market faces a significant restraint due to the intricacies involved in vaccine development, which includes extensive clinical trials and comprehensive testing protocols. These processes are not only time-consuming but also entail substantial financial investments, leading to high development costs for vaccine manufacturers. Such economic burdens can deter smaller companies from entering the market or limit innovation, ultimately constraining the overall growth potential of the vaccines market. Additionally, the lengthy timelines required for regulatory approval further exacerbate the challenge, making it difficult for new vaccines to be introduced swiftly to address emerging health threats.

Market Trends of the Global Vaccines Market

The global vaccines market is experiencing a notable trend towards personalized vaccines, driven by the increasing demand for personalized medicine and advancements in healthcare technology. Companies are increasingly focusing on developing tailored vaccines that cater to individual patient profiles, thereby enhancing efficacy and improving overall health outcomes. This shift not only opens new avenues for vaccine providers but also aligns with evolving patient expectations for customized healthcare solutions. As the landscape of immunization evolves, the integration of personalized vaccination strategies is anticipated to revolutionize the market, presenting significant growth opportunities and fortifying the commitment to improved public health initiatives.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
PESTEL Analysis
Macro-Economic Indicators
Case Study Analysis
Customer & Buying Criteria Analysis

Vaccines Market by Technology

Market Overview
Conjugate Vaccines
Recombinant Vaccines
Inactivated & Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
MRNA Vaccines
Other Vaccines

Vaccines Market by Type

Market Overview
Multivalent Vaccines
Monovalent Vaccines

Vaccines Market by Disease Indication

Market Overview
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
RSV
Other Disease Indications

Vaccines Market by Route of Administration

Market Overview
Oral Route (PO)
Intranasal Route (NAS)
Subcutaneous Route (Subcut)
Intramuscular Route (IM)

Vaccines Market by End User

Market Overview
Adult Vaccines
Pediatric Vaccines

Vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

GSK Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK-Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt., Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Biotec (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological E Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinovac (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incepta Pharmaceuticals Ltd. (Bangladesh)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valneva SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VBI Vaccine Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Farma (Indonesia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microgen (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZHI FEI Biological (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments